Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation.

by Erika Terzuoli, Stefania Meini, Paola Cucchi, Claudio Catalani, Cecilia Cialdai, Carlo Alberto Maggi, Antonio Giachetti, Marina Ziche, Sandra Donnini
Published 2014-01-01